CDISC SDTM Pharmacokinetic Parameter Long Name Terminology

Known as: PK Parameters, PKPARM, SDTM-PKPARM 
Terminology associated with the pharmacokinetic parameter test name codelist of the Clinical Data Interchange Standards Consortium (CDISC) Study Data… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Minimal physiologically-based pharmacokinetic (mPBPK) models provide a sensible modeling approach when fitting only plasma (or… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2012
2012
QDMRK was a phase III clinical trial of raltegravir given once daily (QD) (800-mg dose) versus twice daily (BID) (400 mg per dose… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2011
2011
Drug pharmacokinetics parameters, drug interaction parameters, and pharmacogenetics data have been unevenly collected in… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 4
Is this relevant?
2010
2010
Tocilizumab is a humanized anti-interleukin-6 (IL-6) receptor monoclonal antibody that has demonstrated efficacy in the treatment… (More)
Is this relevant?
2010
2010
Using simulated viral load data for a given maraviroc monotherapy study design, the feasibility of different algorithms to… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2005
2005
BACKGROUND Enoxaparin is the only low molecular-weight heparin (LMWH) with documented efficacy for the prevention of venous… (More)
Is this relevant?
2005
2005
We generated a human/mouse chimeric antibody c-SN6j of human IgG1 isotype from a murine anti-human endoglin (EDG) monoclonal… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Dose [-concentration]-effect relationships can be obtained by fitting a predictive pharmacokinetic (PK)-pharmacodynamic (PD… (More)
  • table I
  • figure 1
  • figure 2
  • table II
  • figure 3
Is this relevant?
2000
2000
Purpose. To evaluate (1) allometric scaling of systemic clearance (CL)using unbound drug concentration, (2) the potential usage… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
1999
1999
In population pharmacokinetic (PK) studies, one observes just a few concentration measures spread out in time, on a sizable… (More)
Is this relevant?